Analysis
| Earnings estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of analysts | 1 | 1 | 33 | 34 |
| Average estimate | 10.81 | 11.63 | 44.83 | 50.48 |
| Low estimate | 10.81 | 11.63 | 41 | 44.70 |
| High estimate | 10.81 | 11.63 | 48.30 | 58.70 |
| Last year EPS | 8.61 | 11.58 | 41.00 | 44.83 |
| Revenue estimate |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Number of Analysts | 3 | 3 | 35 | 35 |
| Avg. estimate | 83.63B | 90.54B | 354.90B | 385.33B |
| Low estimate | 82.68B | 88.90B | 341.41B | 364.03B |
| High estimate | 84.29B | 92.33B | 372.62B | 412.33B |
| Last year sales | 80.28B | 85.49B | 339.06B | 306.88B |
| Sales growth | 0.04 | 0.06 | 0.05 | 0.26 |
| EPS trend |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Current estimate | 10.81 | 11.63 | 44.83 | 50.48 |
| 7 days ago | 10.67 | 11.56 | 45.57 | 51.40 |
| 30 days ago | 10.67 | 11.56 | 45.72 | 51.50 |
| 60 days ago | 11.40 | 12.35 | 45.69 | 51.41 |
| 90 days ago | 11.40 | 12.35 | 48.81 | 54.46 |
| EPS revisions |
Current quarter (Sep 2025) |
Next quarter (Dec 2025) |
Current year (Mar 2026) |
Next year (Mar 2027) |
|---|---|---|---|---|
| Up last 7 days | 0 | 0 | 7 | 6 |
| Up last 30 days | 0 | 0 | 7 | 7 |
| Down last 7 days | 0 | 0 | 0 | 0 |
| Down last 30 days | 1 | 0 | 16 | 18 |